Please assess the completion status of the following clinical trial:

Trial Title: Palliation Dysphagia Cancer Oesophagus Stent+Brachytherapy Versus Brachytherapy Only

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patients must fulfill all the following criteria:~1. Histologically or cytologically verified carcinoma of the oesophagus~2. Reduced ability to swallow solid food, minimum grade 1 (see page 16)~3. Age ≥ 18 years~4. Ability to understand and answer (with or without help) the study questionnaires~5. Written informed consent received~6. A Completed questionnaire received from the patient~7. One of the following criteria must be fulfilled:~   1. Advanced disease and WHO performance status ≥2~  2. Advanced disease and WHO performance status 0-1 and other therapy excluded due to medical condition~  3. Advanced disease and WHO performance status 0-1 and patient's preference~  4. Local disease and WHO performance status ≥2 and other therapy excluded due to medical condition~  5. Local disease and WHO performance status ≥2 and patient's preference~Exclusion Criteria:~1. Oesophageal stent already inserted~2. Endoscopic procedures not tolerated~3. Cannot have (additional) radiation therapy~4. Tumour location not suited for stent or brachytherapy (the upper 3 cm of oesophagus or major component in the cardia)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): Stent followed by 3 brachytherapy fractions
- B (Type: ACTIVE_COMPARATOR): 3 fractions of brachytherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).